Genvoya and Flonase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Genvoya (cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate) and Flonase (fluticasone propionate). Common drug interactions include osteopenia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Genvoya and Flonase. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Genvoya?

Genvoya has active ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 13,538 Genvoya users. Check the latest studies of Genvoya.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.



On Jul, 08, 2026

45 people who take Genvoya and Flonase together, and have interactions are studied.

Genvoya and Flonase drug interactions.

What are the common drug interactions of Genvoya and Flonase, by gender? *:

female:

  1. Osteopenia (a condition where bone mineral density is lower than normal)
  2. Pain
  3. Abdominal pain upper
  4. Bone density decreased
  5. Death
  6. Decreased appetite
  7. Headache (pain in head)
  8. Osteoporosis (bones weak and more likely to break)
  9. Tooth loss
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

male:

  1. Anxiety
  2. Pain
  3. Migraine (headache)
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Renal impairment (severely reduced kidney function)
  6. Dyspnoea (difficult or laboured respiration)
  7. Hypertension (high blood pressure)
  8. Fatigue (feeling of tiredness)
  9. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  10. Asthma

What are the common drug interactions of Genvoya and Flonase, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Osteonecrosis (death of bone)
  5. Pain
  6. Renal failure (kidney dysfunction)
  7. Bone density decreased
  8. Bone loss
  9. Depression
  10. Hydronephrosis (water inside the kidney)

40-49:

  1. Foot fracture
  2. Gait disturbance
  3. Hand fracture
  4. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  5. Mobility decreased (ability to move is reduced)
  6. Osteoporosis (bones weak and more likely to break)
  7. Spinal compression fracture (fracture due to spinal compression on bone)
  8. Tibia fracture (fracture of lower leg bone)
  9. Chronic kidney disease
  10. Anxiety

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Chronic kidney disease
  6. Foot fracture
  7. Osteopenia (a condition where bone mineral density is lower than normal)
  8. Avulsion fracture (bone fracture)
  9. Bone density decreased
  10. Cardiac arrest

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Joint swelling
  4. Oedema peripheral (superficial swelling)
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Emotional distress
  7. Pain
  8. Humerus fracture (injury to the upper arm bone)
  9. Migraine (headache)
  10. Multiple injuries

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 13.33%
  2. High Blood Pressure: 4 people, 8.89%
  3. Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 3 people, 6.67%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Genvoya and Flonase?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Genvoya and Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Genvoya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Genvoya and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flonase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate and fluticasone propionate (the active ingredients of Genvoya and Flonase, respectively), and Genvoya and Flonase (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: